Home
Regulatory UpdatesSep 8, 2026•1 min read

Marshall Pharma Prednisone Tablet (5 mg) ANDA080301 Discontinued

By the PharmaCountry team

FDA records indicate Marshall Pharma's oral prednisone 5 mg tablet (product 001) under application ANDA080301 is listed as discontinued.

The FDA’s ANDA080301 filing for Marshall Pharma lists a single oral product: Prednisone 5 mg tablets (product number 001). The product is classified as a tablet dosage form, contains the active ingredient prednisone at a strength of 5 mg, and is marked as a discontinued marketing status. No reference drug or reference standard is indicated. Sponsor: Marshall Pharma.

Compiled by the PharmaCountry team · Source: FDA.gov

More articles

View all insights